[1] Dunne S, Mooney O, Coffey L, et al.Psychological variables associated with quality of life following primary treatment for head and neck cancer: a systematic review of the literature from 2004 to 2015[J]. Psychooncology, 2017, 26(2): 149-160. [2] Schmidt BL.The neurobiology of cancer pain[J]. J Oral Maxillofac Surg, 2015, 73(12 Suppl): S132-135. [3] Paice JA, Ferrell B.The management of cancer pain[J]. CA Cancer J Clin, 2011, 61(3): 157-182. [4] 陈彬彬,孟娜,黄思婷,等.下丘脑室旁核胶质细胞活化在大鼠炎性痛调节过程中的作用[J].中国药理学通报,2018, 34(8): 1094-1098. [5] Yu T, Zhang X, Shi H, et al.P2Y12 regulates microglia activation and excitatory synaptic transmission in spinal lamina Ⅱ neurons during neuropathic pain in rodents[J]. Cell Death Dis, 2019, 10(3): 165-180. [6] Asano S, Hayashi Y, Iwata K, et al.Microglia-astrocyte communication via c1q contributes to orofacial neuropathic pain associated with infraorbital nerve injury[J]. Int J Mol Sci, 2020, 21(18): 6834-6848. [7] Chen Y, Cai Z, Ke Z.Antineuroinflammation of minocycline in stroke[J]. Neurologist, 2017, 22(4): 120-126. [8] Kopruszinski CM, Dos Reis RC, Gambeta E, et al.Blockade of endothelin receptors reduces tumor-induced ongoing pain and evoked hypersensitivity in a rat model of facial carcinoma induced pain[J]. Eur J Pharmacol, 2018, 818: 132-140. [9] Mizuno M, Minato K, Ito H, et al.Anti-tumor polysaccharide from the mycelium of liquid-cultured Agaricus blazei mill[J]. Biochem Mol Biol Int, 1999, 47(4): 707-714. [10] Zhao H, Alam A, Chen Q, et al.The role of microglia in the pathobiology of neuropathic pain development: what do we know?[J]. Br J Anaesth, 2017, 118(4): 504-516. [11] Jeong H, Na YJ, Lee K, et al.High-resolution transcriptome analysis reveals neuropathic pain gene-expression signatures in spinal microglia after nerve injury[J]. Pain, 2016, 157(4): 964-976. [12] Apryani E, Ali U, Wang ZY, et al.The spinal microglial IL-10/beta-endorphin pathway accounts for cinobufagin-induced mechanical antiallodynia in bone cancer pain following activation of alpha7-nicotinic acetylcholine receptors[J]. J Neuroinflammation, 2020, 17(1): 75-92. [13] Zhou KX, He XT, Hu XF, et al.XPro1595 ameliorates bone cancer pain in rats via inhibiting p38-mediated glial cell activation and neuroinflammation in the spinal dorsal horn[J]. Brain Res Bull, 2019, 149: 137-147. [14] Lam DK, Schmidt BL.Orofacial pain onset predicts transition to head and neck cancer[J]. Pain, 2011, 152(5): 1206-1209. [15] Liu X, Jiao K, Jia CC, et al.BAP31 regulates IRAK1-dependent neuroinflammation in microglia[J]. J Neuroinflammation, 2019, 16(1): 281-295. [16] Tang Y, Liu L, Xu D, et al.Interaction between astrocytic colony stimulating factor and its receptor on microglia mediates central sensitization and behavioral hypersensitivity in chronic post ischemic pain model[J]. Brain Behav Immun, 2018, 68: 248-260. [17] Liu Q, Zhang Y, Liu S, et al.Cathepsin C promotes microglia M1 polarization and aggravates neuroinflammation via activation of Ca2+-dependent PKC/p38MAPK/NF-kappaB pathway[J]. J Neuroinflammation, 2019, 16(1): 10-27. [18] Kirkley KS, Popichak KA, Afzali MF, et al.Microglia amplify inflammatory activation of astrocytes in manganese neurotoxicity[J]. J Neuroinflammation, 2017, 14(1): 99-115. [19] Wu M, Xu L, Wang Y, et al.S100A8/A9 induces microglia activation and promotes the apoptosis of oligodendrocyte precursor cells by activating the NF-kappaB signaling pathway[J]. Brain Res Bull, 2018, 143: 234-245. [20] Sharma M, Arbabzada N, Flood PM.Mechanism underlying beta2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells[J]. J Neuroimmunol, 2019, 332: 37-48. [21] Wang B, Huang X, Pan X, et al.Minocycline prevents the depressive-like behavior through inhibiting the release of HMGB1 from microglia and neurons[J]. Brain Behav Immun, 2020, 88: 132-143. [22] Naderi Y, Sabetkasaei M, Parvardeh S, et al.Neuroprotective effect of minocycline on cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory and anti-oxidant properties in male rat[J]. Brain Res Bull, 2017, 131: 207-213. [23] Daulatzai MA.Pharmacotherpy and alzheimer's disease: the m-drugs (melatonin, minocycline, modafinil, and memantine) approach[J]. Curr Pharm Des, 2016, 22(16): 2411-2430. |